Metastatic castration-resistant prostate cancer has poor survival outcomes. New prognostic gene panels are being used in developing ways to interrogate the likely natural history of an individual's disease. Biomarker innovations to calculate tumour burden also hold promise for the future, but there is still some way to go to validate and stratify their use.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.euf.2016.09.001 | DOI Listing |
Publication Analysis
Top Keywords
prostate cancer
8
biomarkers manage
4
manage men
4
men metastatic
4
metastatic prostate
4
cancer day
4
day metastatic
4
metastatic castration-resistant
4
castration-resistant prostate
4
cancer poor
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!